Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Yes, have you?
belgrano, you have zero credibility here. You spent years ramping and stating your opinions as fact. You have run out of patience and sold up.
Please leave quietly instead of constantly bleating on and on about why you sold and are not getting back in. Are you trying to convince the investors or yourself, that you made the right decision, to pacify your conscience? I don't think we're interested thanks.
So what is Optibac's psoriasis product? Can't seem to find it. All I can see is a slick advertising and self promotional website with numerous different bacterial products, but no specific claims, ie. this for 'A' this is for 'B'. Their research claims seem to be based on years old studies, the latest on being from 2019.
Am I missing something?
Might be worth revisiting PBX September RNS for more details.
Or, is PBX a better bet than OPTI? Controversial I know, but isn't the PBX IP worth a fair bit, what with the Pharma trial going on?
Just a thought........or have I got my wires crossed?
There's no such thing as a free lunch Mr Jones.
I was hoping the PBX allotment would go some way to recovering my losses on OPTI.
I probably won't get access to them until they're worthless.
What a disaster of an investment.
Got to say, the retail total was very disappointing =~( However the directors have stumped up a few quid in the placing =~)
The corporate team at Penningtons Manches Cooper has advised SkinBioTherapeutics plc (AIM: SBTX) on a £2.5 million placing, and a separate retail offer to existing shareholders through the REX platform, raising an additional £117,378.